US EditionBiofarm reports a 33% increase in turnover in the first quarter of 2025 - Business Review
Summary by Business Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Biofarm reports a 33% increase in turnover in the first quarter of 2025 - Business Review
Biofarm (stock symbol BIO), one of the largest pharmaceutical producers in Romania, recorded a 33% increase in turnover compared to Q1 2024. EBITDA grew by 51%, reaching RON 40.5 million, while net profit rose by approximately 57%. These results reflect the efficiency of the company’s operational model and the improved commercial performance. “The results […] The post Biofarm reports a 33% increase in turnover in the first quarter of 2025 appe…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
